<DOC>
	<DOC>NCT00597051</DOC>
	<brief_summary>The purpose of this study is to determine which dose, if any, results in testosterone levels within the normal range for men.</brief_summary>
	<brief_title>Study of 3 Doses of ARD-0403 in Testosterone Deficient Men</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Testosterone deficiency Normal BMI Previous treatment with testosterone replacement therapy within 4 weeks Moderatesevere benign prostatic hypertrophy, or prostatic cancer Haematocrit &gt;50%</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>